| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,300 | 1,505 | 23:00 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| DIAGNOSTIC MEDICAL SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 17:53 | DMS GROUP: FURTHER STRONG GROWTH IN ANNUAL RESULTS FOR THE 2025 FINANCIAL YEAR | 196 | Actusnews Wire | FURTHER STRONG GROWTH IN ANNUAL RESULTS FOR THE 2025 FINANCIAL YEAR
Solid growth in activity of +8.5% in 2025 to €50 million, driven by sustained international development and the North American... ► Artikel lesen | |
| 07.04. | DMS GROUP OBTAINS EUROPEAN MDR CERTIFICATION FOR ITS STRATOS BONE DENSITOMETER RANGE | 276 | Actusnews Wire | April 7, 2026 - 6:00 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry... ► Artikel lesen | |
| 27.03. | DMS GROUP: THE EUROPEAN INVESTMENT BANK GRANTS A FINANCING LINE OF UP TO EUR 20 MILLION | 1.407 | Actusnews Wire | Funding with the support of the European Union, through InvestEU, to accelerate the development of the new generation of medical imaging solutions as part of the next strategic plan Imaging 2030... ► Artikel lesen | |
| 11.03. | Sono-Tek Corporation: Sono-Tek Announces $820K Order for Diagnostic Medical Device Coating Systems | 300 | GlobeNewswire (Europe) | MILTON, N.Y., March 11, 2026 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it has received a purchase... ► Artikel lesen | |
| 19.01. | DMS GROUP: EUR 50.0 MILLION IN ANNUAL REVENUE IN 2025, ORGANIC GROWTH OF +9% | 4.367 | Actusnews Wire | Dynamic growth of +17% in activity in Q4 2025, driven by sustained international development
Confirmed acceleration in growth in the 2nd half of 2025 (+14% vs. +3% in the 1st half of 2025)... ► Artikel lesen | |
| 06.01. | DMS GROUP: HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT ON DECEMBER 31, 2025 | 328 | Actusnews Wire | January 6, 2026 - 5.45 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry... ► Artikel lesen | |
| 04.11.25 | DMS GROUP RECEIVES FDA CLEARANCE FOR ITS !M1 MOBILE RADIOLOGY SYSTEM AS PART OF ITS PARTNERSHIP WITH JPI HEALTHCARE SOLUTIONS IN THE UNITED STATES | 917 | Actusnews Wire | A new strategic milestone in DMS Group's expansion in North America ahead of RSNA 2025
November 4, 2025 - 5:45 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS), a... ► Artikel lesen | |
| 20.10.25 | DMS GROUP: ACCELERATION OF GROWTH IN THE 3RD QUARTER 2025 | 867 | Actusnews Wire | Quarterly revenue of €11.0 million, up +10%
Dynamism in the Radiology business (+15% in Q3)
Confirmation of the objective of accelerating growth in the 2nd half of 2025 in a less dynamic... ► Artikel lesen | |
| 29.09.25 | DMS GROUP: SUSTAINED GROWTH IN HALF-YEAR RESULTS FOR 2025 | 1.074 | Actusnews Wire | New half-year of business growth (+3%) in the 1st half of 2025, in a demanding international environment
Strong EBITDA growth of +82% - EBITDA margin of 7.2% (vs. 4.1%)
+€1.2 million improvement... ► Artikel lesen | |
| 18.08.25 | DMS Group: An International Alliance For European Technological Sovereignty In Medical Imaging - Capital Increase Of A Total Amount Of Eur 6.9 Million Reserved For Innolux, Innocare, Bpifrance And NextStage AM | 832 | Actusnews Wire | A major international industrial alliance, supported by major institutional investors.
DMS Group, a fast-growing European industrial player, is joining forces with two listed Asian technology... ► Artikel lesen | |
| 21.07.25 | DMS GROUP: FURTHER INCREASE IN REVENUE +3% IN H1 2025 | 1.289 | Actusnews Wire | Further increase in a tense market environment and an unfavorable base effect
A 2nd half of 2025 expected to see sustained growth, driven by the implementation of the Ukraine contract and the... ► Artikel lesen | |
| 17.06.25 | STRENGTHENING OF DMS GROUP'S GOVERNANCE STRUCTURE: APPOINTMENT OF JULIEN DELPECH AS AN INDEPENDENT DIRECTOR | 514 | Actusnews Wire | June 17, 2025 - 8:00 am - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS and FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for digital... ► Artikel lesen | |
| 12.06.25 | DMS GROUP: INITIATION OF COVERAGE OF THE STOCK BY ODDO BHF | 586 | Actusnews Wire | June 12, 2025 - 6:00 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS and FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for Digital... ► Artikel lesen | |
| 12.05.25 | DMS GROUP: FDA CLEARANCE FOR THE !M1 SYSTEM AND THE IMMEDIATE COMMERCIALIZATION IN THE UNITED STATES WITH MEDLINK IMAGING | 625 | Actusnews Wire | May 12, 2025 - 8:00 AM - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS et FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for Digital... ► Artikel lesen | |
| 07.05.25 | DMS GROUP: IMPLEMENTATION OF A LIQUIDITY CONTRACT WITH NATIXIS ODDO BHF | 569 | Actusnews Wire | May 7, 2025 - 8:00 AM - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS et FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for Digital Radiology... ► Artikel lesen | |
| 22.04.25 | 2025 FIRST-QUARTER REVENUE: DMS GROUP RECORDS DOUBLE-DIGIT GROWTH | 768 | Actusnews Wire | A growth dynamic that will accelerate by the end of the first half of the year, driven by the start of mobile M1 deliveries in Ukraine
€10.9 M
Turnover
10%
Increase in turnover vs. first... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CROSS COUNTRY HEALTHCARE | 8,100 | +1,25 % | Cross Country Healthcare ernennt Amiee Hawkins zur neuen COO | ||
| LNA SANTE | 28,000 | 0,00 % | LNA SANTE: 2025 Annual Results | ||
| FRESENIUS | 44,850 | +0,81 % | Fresenius: S&P Global erhöht Ausblick - jetzt zugreifen? | Unter der Leitung von Konzernchef Michael Sen hat sich Fresenius einem Umbau unterzogen. Randbereiche wurden verkauft, die Effizienz gesteigert und schlussendlich auch der Schuldenabbau forciert. Das... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,650 | -0,92 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,290 | +1,32 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 52 auf 45 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Vor der Berichtssaison... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,280 | +1,48 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| PROGYNY | 17,170 | +1,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 24,590 | +4,82 % | PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 | ||
| ADAPTHEALTH | 12,770 | +3,74 % | AdaptHealth refinances $1.1B senior secured credit facility | ||
| CARL ZEISS MEDITEC | 27,100 | +3,20 % | GOLDMAN SACHS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Carl Zeiss Meditec von 36 auf 31 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Die Aktien der Jenaer... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,700 | +5,23 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106 Augenapplikatoren | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Zulassungsgenehmigung
Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106... ► Artikel lesen | |
| GERRESHEIMER | 17,400 | +1,87 % | Gerresheimer muss SDAX verlassen - exotischer Nachrücker | Es hat sich bereits abgezeichnet: Der angeschlagene Spezialverpackungshersteller Gerresheimer muss den SDAX bereits zum morgigen 10. April verlassen. Die Düsseldorfer haben es versäumt, den testierten... ► Artikel lesen | |
| DRAEGERWERK | 97,00 | +1,89 % | Draegerwerk AG & Co. KGaA: Online-Präsentation für Investoren als Teil der German Select 7 Conference am 14.04.2026 | Vor diesem Hintergrund veranstaltet mwb research am 14.04.2026 um 14:00 CEST einen Online-Roundtable mit Thomas Fischler (Head of Treasury & Investor Relations). Nach einer Präsentation besteht die... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 46,040 | -0,04 % | BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026 | ||
| MIMEDX | 3,920 | +0,26 % | MiMedx Group, Inc: MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX Thyroid Shields | MARIETTA, Ga., March 05, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced the commercial launch of AMNIOFIX Thyroid Shields, a product line extension... ► Artikel lesen |